Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Emerging Therapies
Emerging Therapies
Cediranib-Based Combination Therapy Extends Progression-Free Survival in Relapsed Ovarian Cancer
Wayne Kuznar
Play Video
Emerging Therapies
CVD Pipeline: Novel Approaches to Modifying Lipids/Lipoproteins
Mary Mosley
Play Video
Emerging Therapies
Dacomitinib Represents Potential New Targeted Therapy for EGFR Mutation–Positive Lung Cancer
Wayne Kuznar
Play Video
Emerging Therapies
Diabetes Drug Pipeline: Promising Agents in Late Stages of Development
Wayne Kuznar
Play Video
Emerging Therapies
Diabetes Drug Pipeline: Promising Agents in Late Stages of Development
Wayne Kuznar
Play Video
Emerging Therapies
Dual-Specific CAR T-Cell Therapy Targets CD19 and CD22 in Patients with Acute Lymphoblastic Leukemia
Chase Doyle
Chase Doyle
Play Video
Emerging Therapies
Elotuzumab, First-in-Class Monoclonal Antibody Immunotherapy, Improves Outcomes in Patients with Multiple Myeloma
Phoebe Starr
Play Video
Emerging Therapies
Empagliflozin Safe and Effective with or without Metformin, Reduces Weight
Mary Mosley
Play Video
Emerging Therapies
Empagliflozin Safe and Effective with or without Metformin, Reduces Weight
Mary Mosley
Play Video
Emerging Therapies
Encouraging Results for Pembrolizumab in Head and Neck Cancer
Phoebe Starr
Play Video
1
2
3
4
5
Page 2 of 7
Results 11 - 20 of 67